RP-13000

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRP-13000
Drug Alias NameNeuroprotectant (Reviva)Nootropic agent (Reviva)RP-13000RP-4000
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReviva Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReviva Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseDementia

Other Information

ATC CodeN/A
Related LinksN/A